CraigDanielSeamanMD

Clotting Disorder, Hemophilia & Bleeding Disorder

Assistant Professor of Medicine

Dr. Seaman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3636 Boulevard of the Allies
Pittsburgh, PA 15213
Phone+1 412-209-7280

Feasibility Study of Unfractionated Heparin in Acute Chest Syndrome Start of enrollment: 2014 May 01
Terminated
Phase 2
Weight-based Dosing in Hemophilia A Start of enrollment: 2015 Sep 01
Terminated
Phase 2

PubMed

33 citations
Venous thromboembolism in pregnant women with sickle cell disease: a retrospective database analysis.
Craig D. Seaman, Jonathan Yabes, Jie Li, Charity G. Moore, Margaret V. Ragni
Thrombosis Research. 2014-12-01
35 citations
Does deficiency of von Willebrand factor protect against cardiovascular disease? Analysis of a national discharge register
Craig D. Seaman, Jonathan Yabes, Diane M. Comer, Margaret V. Ragni
Journal of Thrombosis and Haemostasis. 2015-11-01
58 citations
SMAC/Diablo-dependent apoptosis induced by nonsteroidal antiinflammatory drugs (NSAIDs) in colon cancer cells
Manu Kohli, Jian Yu, Craig D. Seaman, Alberto Bardelli, Kenneth W. Kinzler
Proceedings of the National Academy of Sciences of the United States of America. 2004-11-30

Abstracts/Posters

Emicizumab Prophylaxis in Patients with Hemophilia _ with and without Inhibitors
Craig D. Seaman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Von Willebrand Disease Minimize Menorrhagia (VWDMin) Trial
Craig D. Seaman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019